+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Clinical Trial Supply and Logistics Market for Pharma 2025-2035

  • PDF Icon

    Report

  • 272 Pages
  • October 2025
  • Region: Global
  • Visiongain
  • ID: 5806107
Overall world revenue for Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 in terms of value the market will surpass US$16.0 billion in 2025, the work calculates. The publisher predicts strong revenue growth through to 2035.

The Clinical Trial Supply and Logistics Market for Pharma 2025-203 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Supply Chain Disruptions Pose Market Challenges

Global supply chains remain highly vulnerable to shocks, whether from pandemics, geopolitical conflicts, or raw material shortages. Rising air freight costs, port congestion, and customs delays disrupt timelines and jeopardise trial integrity. These challenges are pushing sponsors to partner with logistics providers that can offer diversified transport options, strategically located regional depots, and robust contingency planning. Providers unable to guarantee business continuity risk both reputational damage and commercial losses. As a result, resilience and redundancy have become critical differentiators in partner selection, reshaping the competitive dynamics of the clinical trial supply and logistics (CTSL) market.

What would be the Impact of US Trade Tariffs on the Global Clinical Trial Supply and Logistics for Pharma Market?

The imposition of U.S. trade tariffs is expected to create ripple effects across the global clinical trial supply and logistics (CTSL) market, particularly as companies dependent on cross-border movement of trial materials face mounting operational costs. Increased tariffs on imported APIs, packaging materials, and specialised equipment can slow procurement processes and tighten budgets, especially for trials that rely on just-in-time delivery models. This environment of heightened uncertainty risks delaying clinical milestones and extending development timelines for new therapies.

Beyond the immediate financial impact, tariffs are likely to influence long-term strategic decisions. Pharmaceutical sponsors and logistics providers may increasingly localise supply chains, invest in regional distribution hubs, or establish tariff-free trade routes to safeguard competitiveness. However, smaller firms with limited resources could struggle to absorb additional costs, widening the gap between global players and niche service providers. In this way, U.S. tariffs not only add pressure to the cost base of trial logistics but also redefine the competitive landscape of the industry.

Key Questions Answered

  • How is the clinical trial supply and logistics for pharma market evolving?
  • What is driving and restraining the clinical trial supply and logistics for pharma market?
  • How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the clinical trial supply and logistics for pharma projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of
clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
  • Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:

  • This 272-page report provides 115 tables and 129 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2035, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Type

  • CTS Manufacturing
  • CTS Logistics & Distribution
  • CT Supply Chain Management
  • CTS Packaging & Storage

Phase

  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles for some of the leading companies in the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

  • Almac Group
  • Bilcare Limited
  • Biocair
  • Catalent, Inc.
  • COREX Logistics
  • Eurofins Scientific
  • FedEx
  • ICON plc
  • Intertek Group plc
  • Kerry Logistics Network Limited
  • Kuehne+Nagel
  • Marken (A UPS Company)
  • Mayne Pharma Group Limited
  • Movianto
  • NAF Pharma
  • Oximio
  • Parexel International Corporation
  • PCI Pharma Services (PCI)
  • Royal Cargo
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • Yourway
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 report help you?

In summary, the 270+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Clinical Trial Supply and Logistics Market for Pharma 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 26 key national markets - See forecasts for the Clinical Trial Supply and Logistics for Pharma Market market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Move Towards Decentralized/Virtual Trials
3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
3.2.1.3 Growing Clinical Trials Volume
3.2.1.4 Integrated Solution to Track Clinical Trials
3.2.2 Market Restraining Factors
3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
3.2.2.2 Man-made or Natural Disruption in Transportation
3.2.2.3 High Financial Cost
3.2.3 Market Opportunities
3.2.3.1 AI and Machine Learning are Evolving with More Data
3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
3.2.3.3 Big Companies are driving the Market
3.1 U.S. Tariffs: What's the Impact on Global Clinical Trial Supply and Logistics for Pharma Market?
3.1.1 Overview
3.1.2 V-Shaped Recovery Scenario
3.1.3 Why V-Shaped Recovery?
3.1.3.1 Impact from Tariffs
3.1.3.2 Market Dynamics and Demand Recovery
3.1.3.3 Policy and Funding Support
3.1.3.4 Timeframe for Recovery
3.1.4 U-Shaped Recovery Scenario
3.1.4.1 Why U-Shaped Recovery?
3.1.4.2 Impact from Tariffs
3.1.4.3 Market Dynamics and Demand Recovery
3.1.4.4 Policy and Funding Support
3.1.4.5 Timeframe for Recovery
3.1.5 L Shaped Recovery Scenario
3.1.5.1 Why L-Shaped Recovery?
3.1.5.2 Impact from Tariffs
3.1.5.3 Market Dynamics and Demand Recovery
3.1.5.4 Policy and Funding Support
3.1.5.5 Timeframe for Recovery
3.1.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
3.1.7 Impact of U.S. and China Trade War on Clinical Trial Supply and Logistics for Pharma Market
3.1.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.2 Porter's Five Forces Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Competitive Rivalry
3.2.4 Threat of Substitutes
3.2.5 Threat of New Entrants
3.3 PEST Analysis
4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
4.4 CTS Manufacturing
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 CTS Logistics & Distribution
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)
4.6 CT Supply Chain Management
4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2025 & 2035 (%)
4.7 CTS Packaging & Storage
4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2025 & 2035 (%)
5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
5.4 Preclinical
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Phase I
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Phase II
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Phase III
5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Phase IV
5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2025 & 2035 (%)
5.9 Post Launch
5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2025 & 2035 (%)
6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
7.1 Key Findings
7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis
8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
8.1 Key Findings
8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
8.13 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
8.14 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
8.15 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
9.1 Key Findings
9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
10.1 Key Findings
10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
10.9 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
10.10 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
10.11 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
11.1 Key Findings
11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
12 Company Profiles
12.1 Catalent, Inc.
12.1.1 Company Snapshot
12.1.2 Company Overview
12.1.3 Financial Analysis
12.1.3.1 Net Revenue, 2020-2024
12.1.3.2 Regional Market Shares, 2024
12.1.4 Service Benchmarking
12.1.5 Strategic Outlook
12.2 Thermo Fisher Scientific Inc.
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2020-2024
12.2.3.2 R&D, 2020-2024
12.2.3.3 Regional Market Shares, 2024
12.2.4 Service Benchmarking
12.2.5 Strategic Outlook
12.3 ICON plc
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Revenue, 2020-2024
12.3.3.2 Regional Market Shares, 2023
12.3.4 Service Benchmarking
12.3.5 Strategic Outlook
12.4 Eurofins Scientific
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2019-2022
12.4.4 Services Offered
12.4.5 Strategic Outlook
12.5 FedEx
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2020-2024
12.5.3.2 Regional Market Shares, 2024
12.5.4 Service Benchmarking
12.6 United Parcel Service, Inc.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2020-2024
12.6.4 Service Benchmarking
12.7 Cencora, Inc.
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2020-2024
12.7.4 Service Benchmarking
12.8 DHL Group
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2020-2024
12.8.4 Service Benchmarking
12.9 DKSH Holding Ltd.
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Service Benchmarking
12.10 KERRY LOGISTICS NETWORK LIMITED
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2019-2023
12.10.3.2 Regional Market Shares, 2024
12.10.4 Service Benchmarking
12.11 Kuehne+Nagel
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2020-2024
12.11.3.2 Regional Market Shares, 2024
12.11.4 Service Benchmarking
12.11.5 Strategic Outlook
12.12 Bilcare Limited
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Service Benchmarking
12.13 Mayne Pharma Group Limited
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Financial Analysis
12.13.3.1 Net Revenue, 2020-2024
12.13.3.2 Regional Market Shares, 2024
12.13.4 Service Benchmarking
12.14 Intertek Group plc
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Financial Analysis
12.14.3.1 Net Revenue, 2020-2024
12.14.4 Service Benchmarking
12.15 Almac Group
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Service Benchmarking
12.15.4 Strategic Outlook
12.16 Parexel International Corporation
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Service Benchmarking
12.16.4 Strategic Outlook
12.17 Biocair
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Service Benchmarking
12.17.4 Strategic Outlook
12.18 Marken (A UPS Company)
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Service Benchmarking
12.19 PCI Pharma Services (PCI)
12.19.1 Company Snapshot
12.19.2 Company Overview
12.19.3 Service Benchmarking
12.19.4 Strategic Outlook
12.20 Movianto
12.20.1 Company Snapshot
12.20.2 Company Overview
12.20.3 Service Benchmarking
12.21 Yourway
12.21.1 Company Snapshot
12.21.2 Company Overview
12.21.3 Service Benchmarking
12.22 COREX Logistics
12.22.1 Company Snapshot
12.22.2 Company Overview
12.22.3 Service Benchmarking
12.23 Oximio
12.23.1 Company Snapshot
12.23.2 Company Overview
12.23.3 Service Benchmarking
12.24 Royal Cargo
12.24.1 Company Snapshot
12.24.2 Company Overview
12.24.3 Service Benchmarking
12.25 NAF Pharma
12.25.1 Company Snapshot
12.25.2 Company Overview
12.25.3 Service Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks
13.2 Recommendations for Market Players
List of Tables
Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): 'V' Shaped Recovery
Table 3 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): 'U' Shaped Recovery
Table 4 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %): 'L' Shaped Recovery
Table 5 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 6 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 10 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 17 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 28 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 31 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 32 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 33 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 34 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 35 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 36 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 37 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 38 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 39 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 40 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 41 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 44 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 45 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 48 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 49 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 51 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 52 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 53 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 54 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 60 Catalent, Inc.: Service Benchmarking
Table 61 Catalent, Inc.: Strategic Outlook
Table 62 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 64 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 65 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 ICON plc: Service Benchmarking
Table 67 ICON plc: Strategic Outlook
Table 68 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 Eurofins Scientific: Services Offered
Table 70 Eurofins Scientific: Strategic Outlook
Table 71 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 FedEx: Service Benchmarking
Table 73 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 United Parcel Service, Inc.: Service Benchmarking
Table 75 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Cencora, Inc.: Service Benchmarking
Table 77 DHL Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 DHL Group: Service Benchmarking
Table 79 DKSH Holding Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 DKSH Holding Ltd.: Service Benchmarking
Table 81 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 KERRY LOGISTICS NETWORK LIMITED: Service Benchmarking
Table 83 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Kuehne+Nagel: Service Benchmarking
Table 85 Kuehne+Nagel: Strategic Outlook
Table 86 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Bilcare Limited: Service Benchmarking
Table 88 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Mayne Pharma Group Limited: Service Benchmarking
Table 90 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Intertek Group plc: Service Benchmarking
Table 92 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Almac Group: Service Benchmarking
Table 94 Almac Group: Strategic Outlook
Table 95 Parexel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Parexel International Corporation: Service Benchmarking
Table 97 Parexel International Corporation: Strategic Outlook
Table 98 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Biocair: Service Benchmarking
Table 100 Biocair: Strategic Outlook
Table 101 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Marken (A UPS Company): Service Benchmarking
Table 103 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 PCI Pharma Services (PCI): Service Benchmarking
Table 105 PCI Pharma Services (PCI): Strategic Outlook
Table 106 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Movianto: Service Benchmarking
Table 108 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Yourway: Service Benchmarking
Table 110 COREX Logistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 COREX Logistics: Service Benchmarking
Table 112 Oximio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Oximio: Service Benchmarking
Table 114 Royal Cargo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Royal Cargo: Service Benchmarking
Table 116 NAF Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 NAF Pharma: Service Benchmarking
List of Figures
Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
Figure 5 Clinical Trials Supply and Logistics Market: Market Dynamics
Figure 6 Clinical Trials Initiated by Phase, 2023
Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 10 Short Term & Long Term Planning
Figure 11 Impact of U.S. and China Trade War
Figure 12 Most Impacted Countries
Figure 13 Clinical Trial Supply and Logistics for Pharma Market: Porter's Five Forces Analysis
Figure 14 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
Figure 15 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 16 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 17 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025, 2030, 2035 (%)
Figure 18 CTS Manufacturing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 CTS Manufacturing Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 20 CTS Logistics & Distribution Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 21 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 22 CT Supply Chain Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 23 CT Supply Chain Management Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 24 CTS Packaging & Storage Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 25 CTS Packaging & Storage Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 26 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 27 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 28 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025, 2030, 2035 (%)
Figure 29 Preclinical Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 30 Preclinical Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Phase I Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 32 Phase I Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 Phase II Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 34 Phase II Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 35 Phase III Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 36 Phase III Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 37 Phase IV Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 38 Phase IV Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 39 Post Launch Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 40 Post Launch Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 41 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 42 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 43 Clinical Trial Supply and Logistics for Pharma Market by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 49 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 50 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 51 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 52 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 53 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 59 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 60 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 61 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 62 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 63 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 64 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 65 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 66 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 67 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 68 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 69 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 70 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 74 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 75 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 76 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 77 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 78 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 79 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 80 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 81 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 82 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 83 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 84 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 85 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 89 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 90 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 91 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 92 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 93 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 94 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 95 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 96 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 97 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 100 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 104 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2025 & 2035 (%)
Figure 105 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2025-2035 (US$ Billion, AGR %)
Figure 106 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2025 & 2035 (%)
Figure 107 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 108 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 109 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 110 Catalent, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 111 Catalent, Inc.: Regional Market Shares, 2024
Figure 112 Thermo Fisher Scientific Inc: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 113 Thermo Fisher Scientific Inc: R&D, 2020-2024 (US$ Million, AGR %)
Figure 114 Thermo Fisher Scientific Inc: Regional Market Shares, 2024
Figure 115 ICON plc: Revenue, 2020-2024 (US$ Million, AGR %)
Figure 116 ICON plc: Regional Market Shares, 2023
Figure 117 Eurofins Scientific: Net Revenue, 2019-2022 (US$ Million, AGR %)
Figure 118 FedEx: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 119 FedEx: Regional Market Shares, 2024
Figure 120 United Parcel Service, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 121 Cencora, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 122 DHL Group: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 123 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 124 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2024
Figure 125 Kuehne+Nagel: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 126 Kuehne+Nagel: Regional Market Shares, 2024
Figure 127 Mayne Pharma Group Limited: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 128 Mayne Pharma Group Limited: Regional Market Shares, 2024
Figure 129 Intertek Group plc: Net Revenue, 2020-2024 (US$ Million, AGR %)

Companies Mentioned

  • Almac Group
  • Bilcare Limited
  • Biocair
  • Catalent, Inc.
  • Cencora, Inc.
  • COREX Logistics
  • DHL Group
  • DKSH Holding Ltd.
  • Eurofins Scientific
  • FedEx
  • ICON plc
  • Intertek Group plc
  • Kerry Logistics Network Limited
  • Kuehne+Nagel
  • Marken (A UPS Company)
  • Mayne Pharma Group Limited
  • Movianto
  • NAF Pharma
  • Oximio
  • Parexel International Corporation
  • PCI Pharma Services (PCI)
  • Royal Cargo
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • Yourway
  • Aramex
  • Cedra Express
  • ClinChoice
  • Concordance Healthcare Solutions LLC
  • Doherty Clinical Trials Ltd.
  • LEO Pharma
  • MilliporeSigma
  • MNX Global Logistics (MNX)
  • Morgan Cargo
  • Novo Holdings
  • Owens & Minor, Inc.
  • Symphogen
  • TrakCel
  • Association of British Pharmaceutical Industry (ABPI)
  • Association for Supply Chain Management (ASCM)
  • Central Drugs Standard Control Organization (CDSCO)
  • Development and Reform Commission (NDRC)
  • European Medicines Agency (EMA)
  • Food and Drug Administration (US FDA)
  • Indian Drug Manufacturer's Association (IDMA)
  • Irish American Business Chamber & Network (IABCN)
  • Korea Food and Drug Administration (KFDA)
  • Korea Pharmaceutical Manufacturer's Association (KPMA)
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medicines Manufacturing Industry Partnership (MMIP)
  • Ministry of Health, Labour and Welfare (MHLW)
  • National Institute for Health and Care Research (NIHR)
  • Pharmaceutical and Medical Devices Agency (PMDA)
  • World Health Organization (WHO)